Author/Creator: Figlin, Robert A. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Figlin, Robert A.

1. Advance Care Planning in Patients With Metastatic Cancer: A Quality Improvement Initiative. Issue 10 (18th October 2022)

Authors:: Oppenheim, Steven; Figlin, Robert A.; Seferian, Edward G.; Reed, Margaret; Irwin, Scott A.; Rosen, Bradley T.
Journal:: JCO oncology practice
Issue:: Volume 18:Issue 10(2022)
Page Start:: e1562
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Characterizing fatigue associated with sunitinib and its impact on health‐related quality of life in patients with metastatic renal cell carcinoma. Issue 12 (13th March 2014)

Authors:: Cella, David; Davis, Mellar P.; Négrier, Sylvie; Figlin, Robert A.; Michaelson, M. Dror; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Sandin, Rickard; Korytowsky, Beata; Charbonneau, Claudie; Matczak, Ewa; Motzer, Robert J.
Journal:: Cancer
Issue:: Volume 120:Issue 12(2014)
Page Start:: 1871
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterizing fatigue associated with sunitinib and its impact on health‐related quality of life in patients with metastatic renal cell carcinoma. Issue 12 (13th March 2014)

Authors:: Cella, David; Davis, Mellar P.; Négrier, Sylvie; Figlin, Robert A.; Michaelson, M. Dror; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Sandin, Rickard; Korytowsky, Beata; Charbonneau, Claudie; Matczak, Ewa; Motzer, Robert J.
Journal:: Cancer
Issue:: Volume 120:Issue 12(2014)
Page Start:: 1871
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinoma. Issue 3 (4th March 2019)

Authors:: Reed, Jarred P.; Posadas, Edwin M.; Figlin, Robert A.
Journal:: Expert review of anticancer therapy
Issue:: Volume 19:Issue 3(2019)
Page Start:: 259
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Expansion of an advance care planning initiative in patients with metastatic cancer: Successes and challenges. Issue 28 (1st October 2022)

Authors:: Oppenheim, Steven; Figlin, Robert A.; Castroll, Rica R; Irwin, Scott A; Isserman, Sean Louis; Hallum, Andrew David; Zorina, Nadejda
Journal:: Journal of clinical oncology
Issue:: Volume 40:Issue 28(2022)Supplement
Page Start:: 197
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Introduction by the Guest Editor: Challenges and Opportunities for the Next Era of Development in Kidney Cancer. Issue 5 (September 2020)

Authors:: Reed, Jarred; Figlin, Robert A.
Journal:: Cancer journal
Issue:: Volume 26:Issue 5(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?. (January 2016)

Authors:: Goldstein, David; Rosenberg, Jonathan E.; Figlin, Robert A.; Townsend, Raymond R.; McCann, Lauren; Carpenter, Christopher; Pandite, Lini
Journal:: European journal of cancer
Issue:: Volume 53(2016)
Page Start:: 96
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?. Issue 11 (27th February 2014)

Authors:: Pal, Sumanta K.; Figlin, Robert A.
Journal:: Cancer
Issue:: Volume 120:Issue 11(2014)
Page Start:: 1604
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?. Issue 11 (27th February 2014)

Authors:: Pal, Sumanta K.; Figlin, Robert A.
Journal:: Cancer
Issue:: Volume 120:Issue 11(2014)
Page Start:: 1604
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Randomized phase 2 trial of erlotinib in combination with high‐dose celecoxib or placebo in patients with advanced non‐small cell lung cancer. Issue 18 (29th May 2015)

Authors:: Reckamp, Karen L.; Koczywas, Marianna; Cristea, Mihaela C.; Dowell, Jonathan E.; Wang, He‐Jing; Gardner, Brian K.; Milne, Ginger L.; Figlin, Robert A.; Fishbein, Michael C.; Elashoff, Robert M.; Dubinett, Steven M.
Journal:: Cancer
Issue:: Volume 121:Issue 18(2015)
Page Start:: 3298
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗